Tech Company Financing Transactions
Waiv Funding Round
Waiv, based in Paris, raised $33 million from Alpha Intelligence Capital, OTB Ventures and Karista.
Transaction Overview
Company Name
Announced On
3/12/2026
Transaction Type
Venture Equity
Amount
$33,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand its portfolio of clinical-grade multimodal tests, deepen its pharmaceutical integrations across R&D pipelines, and broaden international market access, enabling more laboratories and healthcare providers to adopt its precision-testing solutions.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
63 Rue Sainte-Anne
Paris, 75002
France
Paris, 75002
France
Phone
Undisclosed
Website
Email Address
Overview
Next-generation oncology care demands next-generation precision tests; We're building upon seven years of medical-AI research to deliver AI tests that ignite biomarker discovery, streamline multimodal diagnostic workflows, and scale precision oncology for patients worldwide. Waiv spearheads scalable AI grounded in medical science to deliver transformative tests for patients, hand-in-hand with the healthcare partners who share the same mission.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meriem Sefta
Browse more venture capital transactions:
Prev: 3/12/2026: Cryptio venture capital transaction
Next: 3/12/2026: Ark Labs venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs